SGMO - Sangamo Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts7678
Avg. Estimate-0.31-0.36-1.21-1.33
Low Estimate-0.44-0.42-1.36-1.75
High Estimate-0.26-0.23-1.150.05
Year Ago EPS-0.18-0.41-0.7-1.21
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts6578
Avg. Estimate17.47M16.38M65.76M85.12M
Low Estimate7M10M54.5M39.6M
High Estimate22.6M27.2M70.2M241.2M
Year Ago Sales26.84M8.07M84.45M65.76M
Sales Growth (year/est)-34.90%102.90%-22.10%29.40%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.21-0.25-0.36-0.34
EPS Actual-0.18-0.41-0.26-0.24
Difference0.03-0.160.10.1
Surprise %14.30%-64.00%27.80%29.40%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.31-0.36-1.21-1.33
7 Days Ago-0.31-0.35-1.23-1.32
30 Days Ago-0.35-0.34-1.36-1.34
60 Days Ago-0.35-0.34-1.36-1.31
90 Days Ago-0.36-0.32-1.37-1.3
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days5N/A63
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1111
Growth EstimatesSGMOIndustrySectorS&P 500
Current Qtr.-72.20%N/AN/A0.02
Next Qtr.12.20%N/AN/A0.06
Current Year-72.90%N/AN/A-0.03
Next Year-9.90%N/AN/A0.14
Next 5 Years (per annum)-17.90%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A